Strategic partnerships Medichecks already collaborates with national retailers, employers, health practitioners, online GP services, and the NHS to deliver remote blood testing. This suggests sales opportunities in expanding partnerships with corporate wellness programs, insurers, and digital health platforms to broaden reach and add testing services to existing networks.

Menopause care expansion Recent acquisition of My Menopause Centre indicates a strategic push into menopause health. There is potential to upsell targeted blood tests and fertility-related panels to menopause clinics, women's health practitioners, and patient groups focusing on hormonal health.

Pathology platform leverage Launch of a pathology platform enhances capacity for diagnostics and supports scale. This creates opportunities to pitch expanded test menus, faster turnaround times, and white-label or partner-enabled testing for clinics and employers needing scalable remote testing capabilities.

Menopause and fertility focus With 150+ tests tracking over 450 biomarkers including hormones and thyroid function, Medichecks can position bundled fertility and menopause screening packages to healthcare providers, fertility clinics, and fertility-focused insurers seeking comprehensive remote testing options.

Market positioning Revenue range and employee size place Medichecks in a mid-market tier with growth momentum. Sales efforts can target mid-sized employers and regional healthcare networks seeking cost-effective, non-subscription blood testing solutions that integrate with existing wellness programs.